|
|
 |
| Home | Site Map | Print this page |
|
About Fibromyalgia References
|
|
|
- Aronoff, G. M. Myofascial pain syndrome and fibromyalgia: a critical assessment and alternate view [see comments]. Clinical Journal of Pain. 1998; 14(1): 74-85.
- Arroyo, J. F. and M. L. Cohen. Abnormal responses to electrocutaneous stimulation in fibromyalgia [see comments]. Journal of Rheumatology. 1993; 20(11): 1925-31.
- Bennett, R. M. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clinic Proceedings. 1999; 74(4): 385-98.
- Bennett, R. M., D. M. Cook, et al. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. Journal of Rheumatology. 1997; 24(7): 1384-9.
- Clauw, D. J. and G. P. Chrousos. Chronic Pain and Fatigue Syndromes: Overlapping Clinical and Neuroendocrine Features and Potential Pathogenic Mechanisms. Neuroimmunomodulation. 1997; 4: 134-153.
- Dessein, P. H., E. A. Shipton, et al. Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain. 1999; 83(2): 313-9.
- Eide, P. K. Wind-up and the NMDA receptor complex from a clinical perspective [see comments]. Eur J Pain. 2000; 4(1): 5-15.
- Evengard, B., C. G. Nilsson, et al. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain. 1998; 78(2): 153-5.
- Evengard, B., R. S. Schacterle, et al. Chronic fatigue syndrome: new insights and old ignorance. Journal of Internal Medicine. 1999; 246(5): 455-69.
- Goldenberg, D. L. Fibromyalgia syndrome a decade later: what have we learned? Archives of Internal Medicine. 1999; 159(8): 777-85.
- Herrero, J. F., J. M. Laird, et al. Wind-up of spinal cord neurones and pain sensation: much ado about something? Progress in Neurobiology. 2000; 61(2): 169-203.
- Khouzam, H. R. Chronic Fatigue Syndrome: Update on Diagnosis and Treatment. Consultant. 2000; 40(8): 1441-1450.
- Leventhal, L. J. Management of fibromyalgia. Annals of Internal Medicine. 1999; 131(11): 850-8.
- Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation, Psychosom Med. 1976 Jan-Feb; 38(1):35-44.
- Moldofsky H, Scarisbrick P, England R, Smythe H. Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med. 1975 Jul-Aug; 37(4):341-51
- Pillemer, S. R., L. A. Bradley, et al. The neuroscience and endocrinology of fibromyalgia. Arthritis & Rheumatism. 1997; 40(11): 1928-39.
- Russell, I. J., M. D. Orr, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis & Rheumatism. 1994; 37(11): 1593-601.
- Simms, R. W., S. H. Roy, et al. Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism [see comments]. Arthritis & Rheumatism. 1994; 37(6): 794-800.
- Wolfe, F, et al. The Prevalence and Characteristics of Fibromyalgia in the General Population. Arthritis and Rheumatism. 1995; 38(1): 19-28.
|
|
|
|
|
